Core Viewpoint - The company, Hehua Co., Ltd. (河化股份), is undergoing a potential change in its controlling shareholder, which may lead to a shift in actual control, as notified by its major shareholder, Ningbo Yinyi Holdings Co., Ltd. [1] Group 1: Shareholder Changes - Hehua Co., Ltd. has received a notification from its controlling shareholder regarding the planning of a share transfer, which may result in a change of control [1] - The company has applied for a trading suspension for its stock starting from July 31, 2025, to ensure fair information disclosure and protect investor interests [1] Group 2: Business Overview - Hehua Co., Ltd. primarily engages in the research, production, and sales of pharmaceutical intermediates and urea processing and sales [1] - The company’s subsidiary, Nansong Pharmaceutical, specializes in the development and production of pharmaceutical intermediates, with key products including anti-malarial, progestogen, and nutritional intermediates, serving both domestic and international markets [1] Group 3: Operational Strategy - The company has established a comprehensive operational framework, including R&D, production facilities, quality inspection centers, and sales departments to meet market demands [2] - Hehua Co., Ltd. plans to expand its product chain, enhance management efficiency, increase R&D investment, and strengthen market development for new products as part of its 2025 operational plan [2][3] Group 4: Financial Performance - In 2024, Hehua Co., Ltd. reported a revenue of 212 million yuan, reflecting a year-on-year growth of 12.81%, and a net profit of 79.25 million yuan, marking a significant increase of 785.62% [3] - In the first quarter of this year, the company achieved a revenue of 40.83 million yuan and a net profit of 1.36 million yuan, indicating a turnaround from previous losses [3]

Group 1: Company Announcements - Upwind New Materials will suspend trading for stock review starting July 31, 2025, due to abnormal price fluctuations from July 9 to July 30, 2025 [2] - XGIMI Technology expects a net profit attributable to shareholders of 88.66 million yuan for the first half of 2025, a year-on-year increase of 2062.33% [4] - CloudWalk Technology has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [5] - Huaheng Biological is planning to issue H-shares and list on the Hong Kong Stock Exchange [6] - Hehua Co., Ltd. is undergoing a control change process, leading to a stock suspension starting July 31, 2025 [9] Group 2: Financial Performance - DingTong Technology reported a net profit of 115 million yuan for the first half of 2025, a year-on-year increase of 134.06%, with a proposed cash dividend of 2 yuan per 10 shares [7] - Jinhe Biological achieved a net profit of 138 million yuan in the first half of 2025, a year-on-year increase of 51.52% [12] - Hisense Home Appliances reported a net profit of 2.077 billion yuan for the first half of 2025, a year-on-year increase of 3.01% [13] Group 3: Corporate Developments - Nanxin Pharmaceutical is planning to acquire a domestic pharmaceutical technology asset group, but there is significant uncertainty regarding the completion of this acquisition [3] - Jinchengzi is planning to acquire 55% of the equity of Changchun Samit Optoelectronics Technology Co., Ltd., leading to a stock suspension starting July 31, 2025 [8] - SanChao New Materials is also planning a control change, resulting in a stock suspension starting July 31, 2025 [10] Group 4: Industry Developments - Changjiang Electric Power plans to invest approximately 26.6 billion yuan in the construction of the Gezhouba Navigation Capacity Expansion Project, with a total construction period of 91 months [8] - Yonghui Supermarket intends to raise no more than 3.992 billion yuan through a private placement to upgrade stores and logistics [8]

公司股票自2025年7月31日(星期四)上午开市起停牌，预计停牌时间不超过2个交易日。 智通财经APP讯，河化股份(000953.SZ)公告，公司近日收到控股股东宁波银亿控股有限公司的通知，其 正在筹划股权转让相关事宜，该事项可能导致公司控股股东及实际控制人发生变更，目前各方尚未签署 相关正式交易协议，拟就相关事项进行进一步论证和磋商。 ...

河化股份（000953）(000953.SZ)公告，公司近日收到控股股东宁波银亿控股有限公司的通知，其正在 筹划股权转让相关事宜，该事项可能导致公司控股股东及实际控制人发生变更，目前各方尚未签署相关 正式交易协议，拟就相关事项进行进一步论证和磋商。 公司股票自2025年7月31日(星期四)上午开市起停牌，预计停牌时间不超过2个交易日。 ...

证券代码：000953 证券简称：河化股份 公告编号：2025-026 2、公司控制权变更事项目前处于商谈阶段，结果尚存在不确定性， 敬请广大投资者关注后续公告，注意投资风险。 公司近日收到控股股东宁波银亿控股有限公司的通知，其正在筹 划股权转让相关事宜，该事项可能导致公司控股股东及实际控制人发 生变更，目前各方尚未签署相关正式交易协议，拟就相关事项进行进 一步论证和磋商，具体情况以各方签订的相关正式交易协议为准。 鉴于该事项正在筹划中，具有较大不确定性。为保证公平信息披 露，维护投资者利益，避免造成公司股价异常波动，根据《深圳证券 交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第 6 号——停复牌》等有关规定，经公司向深圳证券交易所申请，公司股 票（股票简称：河化股份，股票代码：000953）自 2025 年7月 31 日 （星期四）上午开市起停牌，预计停牌时间不超过 2 个交易日。 股票停牌期间，公司将根据相关事项进展情况，严格按照有关法 律法规的规定和要求履行信息披露义务。待上述事项确定后，公司将 及时发布相关公告并申请公司股票复牌。 广西河池化工股份有限公司 关于筹划公司控制权变更事项的停牌 ...

河化股份公告，公司股票自2025年7月31日起停牌，预计停牌时间不超过2个交易日。公司控股股东宁波 银亿控股有限公司正在筹划股权转让相关事宜，该事项可能导致公司控股股东及实际控制人发生变更。 目前各方尚未签署相关正式交易协议，拟就相关事项进行进一步论证和磋商。 ...

Market Overview - The Shanghai Composite Index closed at 3615.72 points, above the five-day moving average, with a change of 0.17% [1] - The total trading volume of A-shares reached 1,870.976 billion yuan [1] Stocks Breaking the Five-Day Moving Average - A total of 370 A-shares have surpassed the five-day moving average today [1] - Notable stocks with significant deviation rates include: - Shiyan Institute (设研院) with a deviation rate of 15.41% and a daily increase of 20.00% [2] - *ST Yun Chuang (*ST云创) with a deviation rate of 12.66% and a daily increase of 28.14% [2] - Zhenan Technology (震安科技) with a deviation rate of 9.13% and a daily increase of 11.29% [2] - Other stocks with smaller deviation rates include: - Guoyao Co. (国药股份), Jintour Environment (劲旅环境), and Triangle Tire (三角轮胎), which have just crossed the five-day moving average [1] Detailed Stock Performance - The following stocks have notable performance metrics: - Shiyan Institute (300732): Latest price 10.62 yuan, five-day moving average 9.20 yuan, turnover rate 19.58% [2] - *ST Yun Chuang (835305): Latest price 18.08 yuan, five-day moving average 16.05 yuan, turnover rate 22.46% [2] - Zhenan Technology (300767): Latest price 15.18 yuan, five-day moving average 13.91 yuan, turnover rate 18.77% [2] - Additional stocks with significant performance include: - *ST Tianwei (688511): Latest price 20.59 yuan, five-day moving average 19.14 yuan, daily increase of 10.34% [2] - Shenma Electric (603530): Latest price 29.23 yuan, five-day moving average 27.21 yuan, daily increase of 10.01% [2]

Group 1 - The Shanghai Composite Index is at 3625.08 points, above the five-day moving average, with an increase of 0.43% [1] - The total trading volume of A-shares is 820.266 billion yuan [1] - A total of 339 A-shares have prices that have surpassed the five-day moving average, with notable stocks showing significant deviation rates [1] Group 2 - The stocks with the highest deviation rates from the five-day moving average include: - Shiyan Institute (300732) with a deviation rate of 15.41% and a daily increase of 20.00% [1] - *ST Tianwei (688511) with a deviation rate of 7.56% and a daily increase of 10.34% [1] - Shenma Electric Power (603530) with a deviation rate of 7.42% and a daily increase of 10.01% [1] - Other stocks with notable performance include: - Hehua Co. (000953) with a deviation rate of 7.39% and a daily increase of 10.01% [1] - Luban Chemical (600727) with a deviation rate of 6.98% and a daily increase of 10.05% [1]

证券代码：000953 证券简称：河化股份 公告编号：2025-024 广西河池化工股份有限公司 第十一届董事会第一次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或者重大遗漏。 广西河池化工股份有限公司（以下简称"公司"）第十一届董事会第一 次会议通知于2025年7月11日以书面和电子邮件的形式发出，会议于2025 年7月21日公司本部三楼会议室以现场及视频会议的形式召开。本次会议 由全体董事共同推举施伟光先生主持，会议应到董事9人，实到董事9人， 公司高管人员列席会议。本次会议的召集和召开程序符合《中华人民共和 国公司法》（以下简称《公司法》）和《广西河池化工股份有限公司章程》 （以下简称《公司章程》）的有关规定。会议经过认真审议，形成如下决 议： 一、审议通过了《关于选举公司第十一届董事会董事长的议案》 选举施伟光先生为公司第十一届董事会董事长（暨法定代表人），董 事长任期与其在本届董事会任期相同。 表决结果：9票同意，0票反对，0票弃权。 二、审议通过了《关于选举公司第十一届董事会副董事长的议案》 选举魏一雪先生为公司第十一届董事会副董事长，副董事长 ...

Core Points - The company held its first meeting of the 11th Board of Directors on July 11, 2025, where key leadership positions were elected and confirmed [1][2] - The company elected Shi Weiguang as the Chairman of the Board and Wei Yixue as the Vice Chairman, both serving terms aligned with the current board [1][2] - The Board established new specialized committees, including the Strategy Committee, Audit Committee, Nomination Committee, and Compensation and Assessment Committee, with designated leaders and members [2][3] - Jiang Luben was reappointed as the General Manager, and Lu Yongzhang as the Chief Financial Officer, both for the same term as the current board [3][4] - The company also reappointed Tan Honggao as the Board Secretary and Liu Xian as the Internal Audit Head, ensuring compliance with relevant regulations [3][4]